New WIC rules include more money for fruits and vegetables for low-income families

[ad_1] The federal program that helps pay for groceries for millions of low-income mothers, babies and young kids will soon emphasize more fruits, vegetables and whole grains, as well as provide a wider choice of foods from different cultures. The final rule changes for the program known as WIC were announced Tuesday by the Food … Read more

Supplement pill that contained mold recalled after 2 deaths, over 100 hospitalizations in Japan

[ad_1] Health supplement products believed to have caused two deaths and sickened more than 100 people have been ordered to be taken off store shelves in Japan, marking the first major recall of a domestically produced supplement in the country.  The products from Kobayashi Pharmaceutical Co., billed as helping to lower cholesterol, contained an ingredient … Read more

Biden releases 2025 budget proposal, laying out vision for second term

[ad_1] Washington — President Biden on Monday released a budget proposal aimed at getting voters’ attention: It would offer tax breaks for families, lower health care costs, smaller deficits and higher taxes on the wealthy and corporations. Unlikely to pass the House and the Senate to become law, the proposal for fiscal 2025 is an … Read more

Explosions, controlled burn in East Palestine train derailment were unnecessary, NTSB official head says

[ad_1] The decision to blow open five tank cars and burn the toxic chemical inside them after a freight train derailed in Eastern Ohio last year wasn’t justified, the head of the National Transportation Safety Board told Congress Wednesday. But she said the key decision-makers who feared those tank cars were going to explode three … Read more

OxyContin marketer agrees to pay $350 million rather than face lawsuits

[ad_1] Supreme court to hear bankruptcy case of Purdue Pharma Supreme court to hear bankruptcy case of Purdue Pharma 00:42 An advertising agency that helped develop marketing campaigns for OxyContin and other prescription painkillers has agreed to pay U.S. states $350 million rather than face the possibility of trials over its role in the opioid … Read more

Philips, maker of millions of recalled sleep apnea machines, agrees to halt U.S. sales

[ad_1] These are the most-Googled questions about sleep These are the most-Googled questions about sleep 03:44 The company behind a global recall of sleep apnea machines said Monday it will stop selling the devices in the U.S., under a tentative agreement with regulators that could cost the manufacturer nearly $400 million. Device maker Philips has … Read more

ADHD medication recalled because bottles may contain completely different drug

[ad_1] Azurity Pharmaceuticals is recalling some of its ADHD and narcolepsy medication because packages of the drug may contain the wrong pills.  The drug maker said in a recent recall notice that it is calling back one lot of Zanzedi 30 mg with lot number F230169A and an expiration date of June 2025. The product is … Read more

Quaker Oats recalls more granola products due to salmonella risk

[ad_1] Quaker Oats expands granola product recall Quaker Oats expands granola product recall due to salmonella risk 00:19 Quaker Oats is expanding a prior recall to include additional cereals, granola bars and snacks sold across the U.S. because they could be contaminated with salmonella. The recalled products are sold throughout the 50 states, Puerto Rico, … Read more

Consulting firm McKinsey agrees to $78 million settlement with insurers over opioids

[ad_1] Consulting firm McKinsey and Co. has agreed to pay $78 million to settle claims from insurers and health care funds that its work with drug companies helped fuel an opioid addiction crisis. The agreement was revealed late Friday in documents filed in federal court in San Francisco. The settlement must still be approved by … Read more

A popular asthma inhaler will be discontinued in January. Here’s what to know.

[ad_1] Warning for asthma patients regarding inhalers Warning for asthma patients regarding inhalers 00:26 Flovent, a popular steroid inhaler used to treat and control asthma symptoms in children and adults, is being discontinued next week as its manufacturer prepares to roll out a generic version of the medication.  Starting on Jan. 1, 2024, GlaxoSmithKline will … Read more